<DOC>
	<DOCNO>NCT00815256</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness collagen cross link ( CXL ) reduce progression mild moderate progressive keratoconus .</brief_summary>
	<brief_title>Safety Effectiveness Collagen Cross Linking Progressive Mild Moderate Keratoconus</brief_title>
	<detailed_description>Keratoconus corneal degeneration characterize bilateral conical protusion corneal thinning . The course disease varies slight irregular astigmatism severe visual impairment due increase protrusion subepithelial scarring . There treatment available stop keratoconus progression . Thus , progressive nature , keratoconus frequent reason keratoplasty worldwide past 3 decade . The collagen crosslinking ( CXL ) technique use riboflavin ultraviolet - A ( UVA ) light recently develop counteract progressive corneal thinning , thus progression keratoconus . With crosslinking , additional covalent bind collagen molecule achieve , stabilize collagen scaffold enhances corneal resistance . Prospective longitudinal randomize case-control study include progressive keratoconus case address evaluate effectiveness collagen cross link ( CXL ) reduce progression mild moderate progressive keratoconus . Progression base increase cone apex keratometry - 0,75 D , alteration - 0,75 D spherical equivalent increase anterior chamber depth Pentacan , period least six month . All patient must 15 40 year old randomize allocate treat control group . Complete exam exam include best correct visual acuity , refraction , IOP , fundoscopy , image exam corneal computerized topographic , pentacan , orbscan , ultrasound pachymetry , esthesiometry , endothelial cell count , HRT II system confocal microscopy , optic coherence tomography ( VISANTE ) , ORA , optic coherence tomography ( Stratus OCT ) dynamic contour tonometry . All exams repeat 1 , 3 , 6 12 month procedure . The cross link perform follow : topical anesthesia , epithelial tissue remove 8.0mm diameter area central cornea , 0,1 % riboflavin solution apply every 2 min , 30 min follow cornea irradiation UVA light wavelength 370 nm irradiance 3 mW/cm2 . During irradiation , drop riboflavin solution continuously apply onto cornea every 5 min .</detailed_description>
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<criteria>Keratoconus patient , progression disease , base increase cone apex keratometry 0,75 D , alteration 0,75 D spherical equivalent increase anterior chamber depth pentacan , period least six month . pregnancy , corneal thickness le 400 Î¼m , history corneal surgery , herpes ocular infection , corneal disease scarring , chemical injury riboflavin allergy</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Cornea degeneration</keyword>
	<keyword>keratoconus</keyword>
	<keyword>collagen cross link</keyword>
	<keyword>CXL</keyword>
	<keyword>Riboflavin</keyword>
</DOC>